Clover Health exec sells 7,289 shares at $4.91
Clover Health Investments executive Jamie L. Reynoso, CEO of Medicare Advantage, reported an open-market sale of Class A Common Stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Clover Health Investments executive Jamie L. Reynoso, CEO of Medicare Advantage, reported an open-market sale of Class A Common Stock. Reynoso sold 7,289 shares at a weighted average price of $4.91 per share under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Reynoso directly holds 2,849,921 shares, so the sale represents a small portion of her overall position.
Insider Trade Summary 10b5-1
Net Seller: 7,289 shares
Net Sell
1 txn
Insider
Reynoso Jamie L.
Role
CEO, Medicare Advantage
Sold
7,289 shs ($36K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 7,289 | $4.91 | $36K |
Holdings After Transaction:
Class A Common Stock — 2,849,921 shares (Direct)
Footnotes (1)
- F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.15, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks:
Key Figures
Shares sold: 7,289 shares
Weighted average sale price: $4.91 per share
Post-transaction holdings: 2,849,921 shares
+3 more
6 metrics
Shares sold
7,289 shares
Open-market sale of Class A Common Stock
Weighted average sale price
$4.91 per share
Reported sale price for the transaction
Post-transaction holdings
2,849,921 shares
Shares held directly after the sale
Transaction date
June 11, 2026
Date of reported open-market sale
Trading plan adoption date
March 12, 2026
Adoption date of Rule 10b5-1 trading plan
Price range of trades
$4.79–$5.15 per share
Range of individual sale prices
Key Terms
Rule 10b5-1 trading plan, weighted average price, Class A Common Stock, open-market sale
4 terms
Rule 10b5-1 trading plan regulatory
"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Class A Common Stock financial
"security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CLOV executive Jamie Reynoso report on this Form 4?
Jamie L. Reynoso reported selling 7,289 shares of Clover Health Class A Common Stock. The shares were sold in an open-market transaction at a weighted average price of $4.91 per share, according to the Form 4 disclosure and its accompanying footnote.
Was Jamie Reynoso’s CLOV stock sale made under a Rule 10b5-1 plan?
Yes. The Form 4 states the sale was effected under a Rule 10b5-1 trading plan. The plan was adopted on March 12, 2026, indicating the transaction was pre-scheduled rather than a discretionary trade based on short-term market conditions.
What role does Jamie Reynoso hold at Clover Health (CLOV)?
Jamie L. Reynoso is identified as an officer of Clover Health, serving as CEO, Medicare Advantage. This title indicates an executive leadership position focused on the company’s Medicare Advantage operations, as disclosed in the Form 4 reporting the share sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.
